» Articles » PMID: 24496140

Long-term Dry Storage of an Enzyme-based Reagent System for ELISA in Point-of-care Devices

Overview
Journal Analyst
Specialty Chemistry
Date 2014 Feb 6
PMID 24496140
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Lateral flow devices are commonly used for many point-of-care (POC) applications in low-resource settings. However, they lack the sensitivity needed for many analytes relevant in the diagnosis of diseases. One approach to achieve higher sensitivity is signal amplification, which is commonly used in laboratory assays, but uses reagents that require refrigeration and inherently requires multiple assay steps not normally compatible with POC settings. Enzyme-based signal amplification, such as the one used in ELISA, could greatly improve the limit of detection if it were translated to a format compatible with POC requirements. A signal-amplified POC device not only requires the reagents to be stored in a stable form, but also requires automation of the multiple sequential steps of signal amplification protocols. Here, we describe a method for the long-term dry storage of ELISA reagents: horseradish peroxidase (HRP) conjugated antibody label and its colorimetric substrate diaminobenzidine (DAB). The HRP conjugate retained ∼80% enzymatic activity after dry storage at 45 °C for over 5 months. The DAB substrate was also stable at 45 °C and exhibited no detectable loss of activity over 3 months. These reagents were incorporated into a two-dimensional paper network (2DPN) device that automated the steps of ELISA for the detection of a malarial biomarker. These results demonstrate the potential of enzyme-based signal amplification for enhanced sensitivity in POC devices for low resource settings.

Citing Articles

Extending the Shelf-Life of Immunoassay-Based Microfluidic Chips through Freeze-Drying Sublimation Techniques.

Moon S Sensors (Basel). 2023; 23(20).

PMID: 37896617 PMC: 10610996. DOI: 10.3390/s23208524.


Post-Assay Chemical Enhancement for Highly Sensitive Lateral Flow Immunoassays: A Critical Review.

Panferov V, Zherdev A, Dzantiev B Biosensors (Basel). 2023; 13(9).

PMID: 37754100 PMC: 10526817. DOI: 10.3390/bios13090866.


Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics.

Link J, Carrell C, Jang I, Barstis E, Call Z, Bellows R Anal Chim Acta. 2023; 1277:341634.

PMID: 37604607 PMC: 10476143. DOI: 10.1016/j.aca.2023.341634.


Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing.

Carrell C, Jang I, Link J, Terry J, Call Z, Panraksa Y Anal Methods. 2023; 15(22):2721-2728.

PMID: 37099406 PMC: 10249653. DOI: 10.1039/d3ay00225j.


Electrochemical Capillary Driven Immunoassay for Detection of SARS-CoV-2.

Clark K, Schenkel M, Pittman T, Samper I, Anderson L, Khamcharoen W ACS Meas Sci Au. 2022; 2(6):584-594.

PMID: 36570470 PMC: 9469961. DOI: 10.1021/acsmeasuresciau.2c00037.


References
1.
Carpenter J, Crowe L, Crowe J . Stabilization of phosphofructokinase with sugars during freeze-drying: characterization of enhanced protection in the presence of divalent cations. Biochim Biophys Acta. 1987; 923(1):109-15. DOI: 10.1016/0304-4165(87)90133-4. View

2.
Nareoja T, Vehniainen M, Lamminmaki U, Hanninen P, Harma H . Study on nonspecificity of an immuoassay using Eu-doped polystyrene nanoparticle labels. J Immunol Methods. 2009; 345(1-2):80-9. DOI: 10.1016/j.jim.2009.04.008. View

3.
Stevens D, Petri C, Osborn J, Spicar-Mihalic P, McKenzie K, Yager P . Enabling a microfluidic immunoassay for the developing world by integration of on-card dry reagent storage. Lab Chip. 2008; 8(12):2038-45. DOI: 10.1039/b811158h. View

4.
Buitink J, van den Dries I, Hoekstra F, Alberda M, Hemminga M . High critical temperature above T(g) may contribute to the stability of biological systems. Biophys J. 2000; 79(2):1119-28. PMC: 1301007. DOI: 10.1016/S0006-3495(00)76365-X. View

5.
Drexler J, Helmer A, Kirberg H, Reber U, Panning M, Muller M . Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2009; 15(10):1662-4. PMC: 2866420. DOI: 10.3201/eid1510.091186. View